Review of the pharmaceutical industry series one- miscalculated out of control failure failure out of favor.docVIP
- 1、本文档共7页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Review of the pharmaceutical industry series one- miscalculated out of control failure failure out of favor
PAGE \* MERGEFORMAT 7
‘Review of the pharmaceutical industry’ series one: miscalculated out of control failure failure out of favor
Enterprise miscalculations
Two years ago, July 1, China’s pharmaceutical industry in the ‘collective rite of pharmaceutical companies’ on the move as a whole on the era of GMP. In walked more than two years of this historic milestone, we come back to find that: some at any cost through the transformation of GMP pharmaceutical companies, they have no feelings of joy and loneliness, much more was the face of new marketing environment and the change in the situation arising from the new confusion and perplexity:
Although the adoption of GMP, a majority of enterprises are still faced with irrational product mix and lower value-added, capital constraints and weak market development, all sorts of obstacles in the fierce competition in the market struggling to sustain a double test of internal and external problems. ‘GMP after the corporate transformation of the anti-risk ability can be greatly improved, marketing advantage will be more clearly highlighted, you can significantly increase its market share’ the good wishes come true. Dun banks and enterprises in the repayment! How to survive financial difficulties? How to deal with fly review? Is to continue to declare a large number of low-cost generic drugs to compete, or development of new medicines through the differentiation develop and expand market reach, or through the commission process to resolve production capacity idle? Many enterprises searched ineffective.
Channel control
In recent years, pharmaceutical companies are also downstream of the pattern of the pharmaceutical distributor has undergone tremendous changes: pharmaceutical distribution industry, the degree of concentration is further increased cross-regional pharmaceutical logistics companies are thriving, pharmaceutical oligopoly circulation pattern will gradually formation. Traditional ‘administrative division di
您可能关注的文档
- 'Inward-seeking' Marketing Inspiration.doc
- 'Intimate contact' consumer insight.doc
- 'Iron Age' coming home appliance brand differentiation increased growth model.doc
- 'Internal rivals' growth trajectory.doc
- 'Internal management and dealer training materials salesman' of new products how to promote-.doc
- 'Is 61'- building a model market model.doc
- 'Invasion of chain' - the jewelry industry's 'impulse' wave.doc
- 'Item of sale of 12 class' serial 2.doc
- 'Iron boss' speed 'foreign air tickets' price cuts General Administration of Civil Aviation of China suffered the cold of winter.doc
- 'Janitor' Crazy.doc
文档评论(0)